{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:39:48Z","timestamp":1649158788842},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T00:00:00Z","timestamp":1434153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["17244120"],"award-info":[{"award-number":["17244120"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s13577-015-0120-8","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T06:19:20Z","timestamp":1434089960000},"page":"46-51","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment and mutation analysis of a novel malignant peritoneal mesothelioma cell line, TU-MM-1, using whole genome sequencing"],"prefix":"10.1007","volume":"29","author":[{"given":"Nao","family":"Oumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Itamochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chikumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kudoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,13]]},"reference":[{"issue":"4","key":"120_CR1","first-page":"293","volume":"24","author":"V Raptopoulos","year":"1985","unstructured":"Raptopoulos V. Peritoneal mesothelioma. Crit Rev Diagn Imaging. 1985;24(4):293\u2013328.","journal-title":"Crit Rev Diagn Imaging"},{"issue":"2","key":"120_CR2","first-page":"32","volume":"9","author":"A Bridda","year":"2007","unstructured":"Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal mesothelioma: a review. MedGenMed. 2007;9(2):32.","journal-title":"MedGenMed"},{"issue":"6","key":"120_CR3","first-page":"1433","volume":"29","author":"I Ahmed","year":"2013","unstructured":"Ahmed I, Ahmed Tipu S, Ishtiaq S. Malignant mesothelioma. Pak J Med Sci. 2013;29(6):1433\u20138.","journal-title":". Pak J Med Sci"},{"issue":"5","key":"120_CR4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","volume":"137","author":"AN Husain","year":"2013","unstructured":"Husain AN, Colby T, Ordonez N, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med. 2013;137(5):647\u201367.","journal-title":"Arch Pathol Lab Med"},{"issue":"1 Suppl","key":"120_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1097-0142(19950101)75:1+<211::AID-CNCR2820751309>3.0.CO;2-X","volume":"75","author":"TM Mack","year":"1995","unstructured":"Mack TM. Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen. Cancer. 1995;75(1 Suppl):211\u201344.","journal-title":"Cancer"},{"issue":"6","key":"120_CR6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18(6):985\u201390.","journal-title":"Ann Oncol"},{"issue":"12","key":"120_CR7","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L","volume":"46","author":"IJ Selikoff","year":"1980","unstructured":"Selikoff IJ, Hammond EC, Seidman H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer. 1980;46(12):2736\u201340.","journal-title":"Cancer"},{"issue":"6","key":"120_CR8","first-page":"2108","volume":"9","author":"PB Illei","year":"2003","unstructured":"Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res. 2003;9(6):2108\u201313.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"120_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","volume":"64","author":"C Thurneysen","year":"2009","unstructured":"Thurneysen C, Opitz I, Kurtz S, Weder W, Stahel RA, Felley-Bosco E. Functional inactivation of NF2\/merlin in human mesothelioma. Lung Cancer. 2009;64(2):140\u20137.","journal-title":"Lung Cancer"},{"issue":"7","key":"120_CR10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott M, Brevet M, Taylor BS, et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet. 2011;43(7):668\u201372.","journal-title":"Nat Genet"},{"issue":"3","key":"120_CR11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/0008-5472.CAN-10-2164","volume":"71","author":"H Murakami","year":"2011","unstructured":"Murakami H, Mizuno T, Taniguchi T, et al. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011;71(3):873\u201383.","journal-title":"Cancer Res"},{"issue":"2","key":"120_CR12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","volume":"75","author":"G Guo","year":"2015","unstructured":"Guo G, Chmielecki J, Goparaju C et al. Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma. Cancer Res. 2015;75(2):264\u20139.","journal-title":"Cancer Res."},{"issue":"1","key":"120_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2014.08.004","volume":"86","author":"T Shukuya","year":"2014","unstructured":"Shukuya T, Serizawa M, Watanabe M, et al. Identification of actionable mutations in malignant pleural mesothelioma. Lung Cancer. 2014;86(1):35\u201340.","journal-title":"Lung Cancer"},{"issue":"1","key":"120_CR14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1245\/s10434-008-0206-6","volume":"16","author":"JM Foster","year":"2009","unstructured":"Foster JM, Gatalica Z, Lilleberg S, Haynatzki G, Loggie BW. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma. Ann Surg Oncol. 2009;16(1):152\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"120_CR15","first-page":"232","volume":"1845","author":"LV Assis de","year":"2014","unstructured":"de Assis LV, Locatelli J, Isoldi MC. The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma. Biochim Biophys Acta. 2014;1845(2):232\u201347.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"120_CR16","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43(10):1022\u20135.","journal-title":"Nat Genet"},{"issue":"7","key":"120_CR17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott M, Brevet M, Taylor BS, et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet. 2011;43(7):668\u201372.","journal-title":"Nat Genet"},{"issue":"5157","key":"120_CR18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","volume":"264","author":"A Kamb","year":"1994","unstructured":"Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264(5157):436\u201340.","journal-title":"Science"},{"issue":"6","key":"120_CR19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","volume":"83","author":"DE Quelle","year":"1995","unstructured":"Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 1995;83(6):993\u20131000.","journal-title":"Cell"},{"issue":"10","key":"120_CR20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","volume":"9","author":"R Brosh","year":"2009","unstructured":"Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer. 2009;9(10):701\u201313.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"120_CR21","first-page":"2610","volume":"52","author":"RA Metcalf","year":"1992","unstructured":"Metcalf RA, Welsh JA, Bennett WP, et al. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res. 1992;52(9):2610\u20135.","journal-title":"Cancer Res"},{"issue":"1","key":"120_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb.16.1.8998073","volume":"16","author":"O Mor","year":"1997","unstructured":"Mor O, Yaron P, Huszar M, et al. Absence of p53 mutations in malignant mesotheliomas. Am J Respir Cell Mol Biol. 1997;16(1):9\u201313.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"19","key":"120_CR23","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.4161\/cc.9.19.13386","volume":"9","author":"S Visser","year":"2010","unstructured":"Visser S, Yang X. LATS tumor suppressor: a new governor of cellular homeostasis. Cell Cycle. 2010;9(19):3892\u2013903.","journal-title":"Cell Cycle"},{"issue":"5","key":"120_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","volume":"8","author":"A Klaus","year":"2008","unstructured":"Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8(5):387\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"6392","key":"120_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/359235a0","volume":"359","author":"SM Powell","year":"1992","unstructured":"Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359(6392):235\u20137.","journal-title":"Nature"},{"issue":"5307","key":"120_CR26","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","volume":"275","author":"V Korinek","year":"1997","unstructured":"Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-\/- colon carcinoma. Science. 1997;275(5307):1784\u20137.","journal-title":"Science"},{"issue":"3","key":"120_CR27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/path.1458","volume":"201","author":"AS Abutaily","year":"2003","unstructured":"Abutaily AS, Collins JE, Roche WR. Cadherins, catenins and APC in pleural malignant mesothelioma. J Pathol. 2003;201(3):355\u201362.","journal-title":"J Pathol"},{"issue":"1","key":"120_CR28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2012","unstructured":"Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2012;12(1):68\u201378.","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"120_CR29","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMra0802968","volume":"359","author":"WD Foulkes","year":"2008","unstructured":"Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med. 2008;359(20):2143\u201353.","journal-title":"N Engl J Med"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-015-0120-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13577-015-0120-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-015-0120-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T19:35:34Z","timestamp":1566848134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13577-015-0120-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1007\/s13577-015-0120-8","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,13]]}}}